Literature DB >> 54789

Letter: Significance of xanthelasma palpebrarum in the normal population.

A Jónsson, N Sigfŭsson.   

Abstract

Mesh：

Year:  1976        PMID： 54789     DOI： 10.1016/s0140-6736(76)90140-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

Authors:  A Jain; P Goyal; P K Nigam; H Gurbaksh; R C Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

2.  Laser treatment of giant xanthelasma palpebrarum.

Authors:  Bartolo Corradino; Sara Di Lorenzo; Antonio Triolo; Francesco Moschella
Journal:  Lasers Med Sci       Date:  2014-09-25       Impact factor: 3.161

3.  Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.

Authors:  Maria S Govorkova; Tatyana Milman; Gui-Shuang Ying; Wei Pan; Rona Z Silkiss
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 May/Jun       Impact factor: 1.746

4.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

5.  Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.

Authors:  Mette Christoffersen; Ruth Frikke-Schmidt; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  BMJ       Date:  2011-09-15

Review 6.  Xanthelasma palpebrarum - a brief review.

Authors:  Pragya A Nair; Rochit Singhal
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-18

7.  Xanthelasma Palpebrarum with Arcus Cornea: A Clinical and Biochemical Study.

Authors:  Pragya Ashok Nair; Chaitali R Patel; Jaishree D Ganjiwale; Nilofar Gulamsha Diwan; Nidhi Bhimjibhai Jivani
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.